Aveo Pharmaceuticals, Inc.
AVEODelisted Jan 19, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001325879
Aveo Pharmaceuticals, Inc. was delisted on Jan 19, 2023; its insiders filed their last Form 4 on Jan 19, 2023; 110 institutions reported holding it in 13F filings for Q4 2022, worth $367.6M in total; no superinvestor held it.
Holders of 5% or more of AVEO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aveo Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Aveo Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Aveo Pharmaceuticals, Inc., newest first.
No Schedule 13D or 13G filings on Aveo Pharmaceuticals, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aveo Pharmaceuticals, Inc. shares.
No Form 144 notices for Aveo Pharmaceuticals, Inc. are on file.